<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>17349255</identifier>
<setSpec>1695-4033</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Argente Oliver, J</dc:author>
<dc:author>Rubio Cabezas, O</dc:author>
<dc:description xml:lang="en">Diabetes is one of the most common chronic diseases. Type 1, or autoimmune, diabetes accounts for more than 95 % of cases in children and adolescents. Chronic hyperglycemia per se is responsible for the development of several microvascular (retinopathy, nephropathy, neuropathy) and macrovascular complications (ischemic heart disease, cerebrovascular disease, and peripheral vascular disease). Other autoimmune diseases are also more frequent in type 1 diabetic patients. The present review aims to provide an update on some recent advances in this field to aid early detection of these complications and prevent or delay their progression through improved metabolic control.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2007 Mar </dc:date>
<dc:title xml:lang="es">Diabetes mellitus en niños y adolescentes: complicaciones crónicas y enfermedades asociadas.</dc:title>
<dc:title xml:lang="en">[Diabetes mellitus in children and adolescents: chronic complications and associated diseases].</dc:title>
<dc:publisher>Anales de pediatria (Barcelona, Spain : 2003)</dc:publisher>
</metadata>
</record>
</pubmed-document>
